Literature DB >> 18650508

Pharmacogenomics and drug toxicity.

Yusuke Nakamura.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18650508     DOI: 10.1056/NEJMe0805136

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  No significant effect of ABCB1 haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin.

Authors:  Jenni E Keskitalo; Kaisa J Kurkinen; Mikko Neuvonen; Janne T Backman; Pertti J Neuvonen; Mikko Niemi
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335

Review 2.  Myopathy with statin-fibrate combination therapy: clinical considerations.

Authors:  Terry A Jacobson
Journal:  Nat Rev Endocrinol       Date:  2009-07-28       Impact factor: 43.330

3.  Effects of simvastatin/ezetimibe on microparticles, endothelial progenitor cells and platelet aggregation in subjects with coronary heart disease under antiplatelet therapy.

Authors:  L M Camargo; C N França; M C Izar; H T Bianco; L S Lins; S P Barbosa; L F Pinheiro; F A H Fonseca
Journal:  Braz J Med Biol Res       Date:  2014-05-02       Impact factor: 2.590

Review 4.  How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion.

Authors:  Douglas B Kell; Stephen G Oliver
Journal:  Front Pharmacol       Date:  2014-10-31       Impact factor: 5.810

Review 5.  Association between SLCO1B1 -521T>C and -388A>G polymorphisms and risk of statin-induced adverse drug reactions: A meta-analysis.

Authors:  Jiajia Jiang; Qing Tang; Jing Feng; Rong Dai; Yang Wang; Yuan Yang; Xiaojun Tang; Changkai Deng; Huan Zeng; Yong Zhao; Fan Zhang
Journal:  Springerplus       Date:  2016-08-19

6.  Harvesting candidate genes responsible for serious adverse drug reactions from a chemical-protein interactome.

Authors:  Lun Yang; Jian Chen; Lin He
Journal:  PLoS Comput Biol       Date:  2009-07-24       Impact factor: 4.475

7.  Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma.

Authors:  Guillermo de Velasco; Kathryn P Gray; Lana Hamieh; Yuksel Urun; Hallie A Carol; Andre P Fay; Sabina Signoretti; David J Kwiatkowski; David F McDermott; Matthew Freedman; Mark M Pomerantz; Toni K Choueiri
Journal:  Eur Urol Focus       Date:  2016-04-23

Review 8.  Dilemmas of the causality assessment tools in the diagnosis of adverse drug reactions.

Authors:  Lateef M Khan; Sameer E Al-Harthi; Abdel-Moneim M Osman; Mai A Alim A Sattar; Ahmed S Ali
Journal:  Saudi Pharm J       Date:  2015-01-10       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.